key: cord-1021673-9vtkmsd6
authors: Okçelik, Sezgin
title: COVID‐19 pneumonia causes lower testosterone levels
date: 2020-11-19
journal: Andrologia
DOI: 10.1111/and.13909
sha: fefee3fe8b8db4f90cb28a7c6245f521e1cb9616
doc_id: 1021673
cord_uid: 9vtkmsd6

To evaluate the testicular damage caused by COVID‐19, we prospectively evaluated 44 patients who applied to the COVID‐19 outpatient clinic between March 2020 and July 2020. Patients' ages, COVID‐19 PCR results, presence of pneumonia, total testosterone, luteinising hormone (LH) and follicle‐stimulating hormone (FSH) values were recorded. It was evaluated whether there were significant differences between people who were positive for COVID‐19 and those who were not. Any differences between those who had COVID‐19 pneumonia and those who did not were also recorded. There was no difference between the FSH, LH and testosterone values of the COVID‐19 PCR positive and negative patients (p = 0.80, vp = 0.62, p = 0.56 respectively). However when LH values were separated as low, normal and high, LH values were statistically significantly higher in the COVID‐19 PCR positive group (p = 0.04). Thoracic computed tomography was performed in 42 patients. Testosterone levels were significantly lower in patients with COVID‐19 pneumonia (p = 0.01). When FSH, LH and testosterone values were separated as low, normal and high, there was no difference in FSH and LH values (p = 1, p = 0.2). Testosterone levels were found significantly lower in patients with COVID‐19 pneumonia (p < .001). Testosterone levels seem to decrease during acute COVID‐19 infection, especially in the patient group with viral pneumonia.

has been demonstrated in testicular tissue, seminiferous duct tissues, spermatogonia, Leydig cells and sertoli cells (Fan et al., 2020; Shen et al., 2020; Wang & Xu, 2020) . The blood testicular barrier is not cannot adequately function to prevent passage through the urogenital system during viraemia (Li et al., 2012) . The fact that orchitis due to COVID-19 has been reported before is evidence of this (Xu et al., 2006) . It can therefore be posited that COVID-19 infection will damage testicular structures. Sperm cells are produced in seminiferous tubules by follicle-stimulating hormone (FSH) effect. Leydig cells are cells that produce testosterone by the luteinising hormone (LH) effect. In the acute period, a decrease in total testosterone (T) values and an increase in LH values can be expected due to the change in the Leydig cells.

However, it is likely that FSH will not be impacted during the acute period, as a longer period of time is required for changes to occur in spermatogenesis. 

To evaluate the testicular damage caused by COVID-19, we prospectively evaluated 44 patients who applied to the COVID-19 outpatient clinic between March 2020 and July 2020. Patients' ages, COVID-19 PCR results, presence of pneumonia, total testosterone, luteinising hormone (LH) and follicle-stimulating hormone (FSH) values were recorded. It was evaluated whether there were significant differences between people who were positive for COVID-19 and those who were not. Any differences between those who had COVID-19 pneumonia and those who did not were also recorded. There was no difference between the FSH, LH and testosterone values of the COVID-19 PCR positive and negative patients (p = 0.80, vp = 0.62, p = 0.56 respectively). However when LH values were separated as low, normal and high, LH values were statistically significantly higher in the COVID-19 PCR positive group (p = 0.04).

Thoracic computed tomography was performed in 42 patients. Testosterone levels were significantly lower in patients with COVID-19 pneumonia (p = 0.01). When FSH, LH and testosterone values were separated as low, normal and high, there was no difference in FSH and LH values (p = 1, p = 0.2). Testosterone levels were found significantly lower in patients with COVID-19 pneumonia (p < .001). Testosterone levels seem to decrease during acute COVID-19 infection, especially in the patient group with viral pneumonia. FSH, LH, pneumonia, Total testosterone In this study, we have aimed to estimate the potential testicular damage caused by this viral infection by evaluating testicular hormone levels in patients at the time of active infection by COVID-19.

With a particular focus on pneumonic patients, we evaluated how this situation was in the group with more severe disease.

After obtaining approval from the Ministry of Health and the Ethics Committee of Hacı Bektaş University, we evaluated patients who had applied to the COVID-19 outpatient clinic with suspicions of COVID-19 between March 2020 and July 2020. Male patients' ages differ from 18 to 50 years being included in the study. Ages of the patients, polymerase chain reaction (PCR) test results of patients with swabs for COVID-19, presence of pneumonia in thoracic computed tomography (CT), total testosterone, LH and FSH values were recorded. Qiagen Rotor-Gene Q 4 ® was used for COVID-19 PCR evaluation. The normal value of the testosterone level was between 9.71 and 27.76 mmol/L. The normal value of LH level was between 1.7 and 8.6 mIU/ml. The normal value of FSH was between 1.5 and 12.4 mIU/ml. The blood for hormonal evaluation was taken at 10 a.m., while the other evaluation blood was taken. It was assessed whether there was a difference between those who were positive for COVID-19 and those who were not. It was also assessed whether there was a significant disparity between the hormones of those who had COVID-19 induced pneumonia and those who did not.

SPSS (17.0) were used for statistical analysis. Statistical evaluation results were reported as mean ± SD or median (minimum − maximum values) according to the normal distribution of variables. The data's distribution was evaluated by the Kolmogorov-Smirnov test.

Mann-Whitney U tests and independent samples tests were used to evaluate the differences between groups. p < 0.05 was considered statistically significant in all evaluations.

Between March 2020 and July 2020, 44 patients were included in the study. The mean age of the patients was 35.5 ± 9.85 years. Only one patient described testicular pain. None of the patients had testicular swelling. The COVID-19 PCR test of 24 patients was positive, and the COVID-19 PCR test of 20 patients was negative. The median FSH value was 3 (1-8) mlU/ml. The median LH value was 5 (2-12) mlU/ ml. The mean total testosterone value was 11.82 ± 5.91 mmol/L.

There was no statistically significant difference between the FSH, LH and total testosterone values of the COVID-19 PCR positive and negative patients (p = 0.80, p = 0.62, p = 0.56 respectively) (Table 1) . When FSH, LH and total testosterone values were divided into categories of low, normal and high, FSH and total testosterone values were similar (p = 1, p = 0.61 respectively). LH values were statistically significantly higher in the COVID-19 PCR positive group (p = 0.04) ( Table 2) .

Thoracic CT was performed on 42 patients. COVID-19 pneumonia was detected in 23 patients. Thorax CT of 19 patients was normal. The FSH and LH values of the patients with COVID-19 pneumonia and those without it were similar (p = 0.61, p = 0.93 respectively) ( Table 3) . When FSH, LH and total testosterone values were separated as low, normal and high, there was no difference found in FSH and LH values (p = 1, p = 0.2 respectively). Total testosterone levels were found to be significantly lower in patients with COVID-19 pneumonia (p < 0.001) ( Table 4 ). . Since ACE2 is expressed in the respiratory system, digestive system, cardiovascular and urinary systems, COVID-19 can also cause disease in these systems (Zou et al., 2020) . The amount of ACE2 mRNA and protein expression within the testes is higher than in many other tissues (Fan et al., 2020) . Some other viral diseases have also been shown to cause viral orchitis and cause male infertility (Xu et al., 2006) . Since the main roles of the testicles are spermatogenesis and the secretion of androgens, sex steroids can be used to assess the male gonad status. A recent study found that testosterone/luteinising hormone ratios were significantly lower in patients with COVID-19 infection (Ma et al., 2020) . In our study, when we segregated FSH, LH and total testosterone values into low, normal and high categories, LH values were found to be significantly high. This supports the thesis that acute testicular damage can be linked to COVID 19 infection by the evaluation of testicular hormones. Furthermore, total testosterone values were significantly lower in patients with viral pneumonia. This result also indicated that COVID-19 infection could cause damage to testicular tissues. Zhao et al. (2003) previously detected SARS-COV2 particles pathologically in seminiferous tubules and Leydig cells. Pan et al. (2020) reported scrotal discomfort in 17.6% COVID-19 positive patients.

However, in this study, the presence of COVID-19 could not be seen in the semen samples. This could be in part because semen turnover was not analysed in this study. Contrary to this study, COVID-19 has been shown to be present in semen (Fan et al., 2020; Wang & Xu, 2020) . In order to better evaluate the effects of COVID-19 infection on semen, future studies should widen the parameters of factors analysed and semen turnover should be measured in each patient.

Previously, Liu et al. (2019) reported that half of the COVID-19 positive patients had acute respiratory distress syndrome (ARDS).

In the acute phase of the disease, decreases in testosterone values were observed (Vanhorebeek et al., 2006) . In our study, testosterone levels were found to be significantly lower but especially in patients with viral pneumonia.

The relatively low number of sampled patients was the limitation of our study. It should be noted that the specificity of COVID-19

PCR is not 100% and that the PCR results of some COVID-19 patients showed negative results. We evaluated COVID-19 pneumonia patients in order to circumvent this limitation. Still, the strength of the study is that the study is prospective and for the first time demonstrates that testicular hormones are affected in patients with COVID-19 viral pneumonia.

Testosterone levels seem to decrease during acute COVID-19 infection, especially in the patient group with viral pneumonia. This suggests to us testicular damage in the acute period. Future studies should evaluate the effect on spermatogenesis by paying attention to sperm turnover, especially in patients with COVID-19 pneumonia.

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Sezgin Okçelik https://orcid.org/0000-0001-6479-9913 

depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor

Structural, cellular and molecular aspects of immune privilege in the testis

Clinical features and progression of acute respiratory distress syndrome in coronavirus disease 2019

Effect of SARS-CoV-2 infection upon male gonadal function: A single center-based study

No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019

The ACE2 expression in Sertoli cells and germ cells may cause male reproductive disorder after SARS-CoV-2 infection

Endocrine aspects of acute and prolonged critical illness

The need for urogenital tract monitoring in COVID-19

scRNA-seq profiling of human testes reveals the presence of the ACE2 receptor, a target for SARS-CoV-2 infection in spermatogonia, leydig and sertoli cells

Orchitis: A complication of severe acute respiratory syndrome (SARS)

Clinical pathology and pathogenesis of severe acute respiratory syndrome

Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection

How to cite this article: Okçelik S. COVID-19 pneumonia causes lower testosterone levels